Study of NBQ72S for breast cancer that has spread to the brain lining
Part of Cancer, Skin clinical trials.
This trial tests a new drug, NBQ72S, for people with breast cancer that has spread to the lining of the brain or spinal cord (leptomeningeal metastasis). It aims to see if the drug is safe and helpful for these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have breast cancer that has spread to the lining of the brain or spinal cord, confirmed by MRI or spinal fluid test.
- You need to be well enough to do daily activities (Karnofsky Performance Status score of 60 or higher).
- Your blood counts, kidney function, and liver function must be within certain ranges (your doctor will check these).
- If you could become pregnant or have a partner who could, you must use effective birth control during treatment and for 7 months after.
- You must not have other active cancers (except for certain skin or in-situ cancers that were treated).
- You must not be allergic to any ingredient in the study drug or to related medications like bendamustine or chloramphenicol.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new targeted therapy for people with HER2-positive breast cancer that has spread to the brain. It aims to see if the drug can help shrink brain tumors and improve outcomes for two groups: those with cancer in the fluid around the brain and those without.
This study looks at genetic material from spinal fluid to better understand breast cancer that has spread to the brain or its lining. It may help doctors find new ways to treat this type of cancer.
This study tests a new drug called TQB3126 for people with breast cancer that has gotten worse after previous treatments. The goal is to see if the drug is safe and helps shrink or slow the cancer.
This study tests a new drug called MT027 for people whose solid tumors (like lung, breast, or colon cancer) have spread to the brain, the lining of the brain, or the spinal cord. It aims to see if the drug is safe and can help shrink or control these cancers.
This trial tests whether a precise type of radiation to the brain and spine (craniospinal irradiation) can help control cancer that has spread to the lining of the brain and spinal cord (leptomeningeal disease) in people with breast cancer or non-small cell lung cancer. The goal is to improve symptoms and slow disease progression.
This study is for people with breast cancer that has spread to the lining of the brain or spinal cord (called leptomeningeal metastasis). Researchers want to understand how to treat this condition and offer care to those who qualify.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.